Vinchi Wang

632 total citations
31 papers, 436 citations indexed

About

Vinchi Wang is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, Vinchi Wang has authored 31 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 11 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Vinchi Wang's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological diseases and metabolism (3 papers) and HER2/EGFR in Cancer Research (3 papers). Vinchi Wang is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological diseases and metabolism (3 papers) and HER2/EGFR in Cancer Research (3 papers). Vinchi Wang collaborates with scholars based in Taiwan, United States and Australia. Vinchi Wang's co-authors include Ming‐Ching Kao, Tzu‐Chao Chuang, Chi‐Ming Chan, Chuen‐Lin Huang, Chi‐Feng Hung, Hsun‐Hsien Chang, Din‐E Shan, Ching‐Yu Lin, Tzu‐Chao Chuang and Bing‐Wen Soong and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Molecules.

In The Last Decade

Vinchi Wang

30 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vinchi Wang Taiwan 12 196 92 72 45 44 31 436
Byung‐Soon Moon South Korea 10 175 0.9× 36 0.4× 51 0.7× 23 0.5× 12 0.3× 51 449
Jie Xiao China 13 257 1.3× 38 0.4× 28 0.4× 34 0.8× 9 0.2× 21 553
Chung‐Hsiang Liu Taiwan 12 92 0.5× 88 1.0× 71 1.0× 18 0.4× 53 1.2× 20 473
Shao-yu Chen United States 10 286 1.5× 19 0.2× 39 0.5× 43 1.0× 23 0.5× 12 701
Shiming Zhang China 11 197 1.0× 101 1.1× 22 0.3× 28 0.6× 7 0.2× 30 431
Jingru Zhao China 13 271 1.4× 31 0.3× 40 0.6× 39 0.9× 11 0.3× 33 622
Hsiang-Yu Tang Taiwan 15 320 1.6× 91 1.0× 23 0.3× 54 1.2× 8 0.2× 37 671
Xiangfang Chen China 13 175 0.9× 20 0.2× 26 0.4× 32 0.7× 24 0.5× 34 462
Yanyan Liu China 12 220 1.1× 22 0.2× 24 0.3× 26 0.6× 14 0.3× 26 461
Huifang Liu China 10 194 1.0× 85 0.9× 56 0.8× 54 1.2× 6 0.1× 33 480

Countries citing papers authored by Vinchi Wang

Since Specialization
Citations

This map shows the geographic impact of Vinchi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinchi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinchi Wang more than expected).

Fields of papers citing papers by Vinchi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinchi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinchi Wang. The network helps show where Vinchi Wang may publish in the future.

Co-authorship network of co-authors of Vinchi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Vinchi Wang. A scholar is included among the top collaborators of Vinchi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinchi Wang. Vinchi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chuang, Tzu‐Chao, Shih‐Chung Hsu, Yi‐Jen Lee, et al.. (2023). Baicalein suppresses HER2 ‐mediated malignant transformation of HER2 ‐overexpressing ovarian cancer cells by downregulating HER2 gene expression. Environmental Toxicology. 38(7). 1609–1617. 5 indexed citations
2.
3.
Wang, Yi Chun, Vinchi Wang, & Bing‐Huei Chen. (2023). Analysis of bioactive compounds in cinnamon leaves and preparation of nanoemulsion and byproducts for improving Parkinson’s disease in rats. Frontiers in Nutrition. 10. 1229192–1229192. 9 indexed citations
5.
Wang, Vinchi, et al.. (2016). Patient- and Hospital-Level Determinants of Rehabilitation for In-Patient Stroke Care. Medicine. 95(19). e3620–e3620. 5 indexed citations
6.
Wang, Vinchi, et al.. (2014). “Do Not Resuscitate” Orders Among Deceased Patients Who Received Acute Neurological Care. Medicine. 93(29). e343–e343. 3 indexed citations
7.
Wang, Vinchi, Tzu‐Chao Chuang, Ming‐Ching Kao, et al.. (2013). Polymorphic Ala-allele carriers at residue 1170 of HER2 associated with Parkinson's disease. Journal of the Neurological Sciences. 325(1-2). 115–119. 5 indexed citations
8.
Chan, Chi‐Ming, Hsun‐Hsien Chang, Vinchi Wang, Chuen‐Lin Huang, & Chi‐Feng Hung. (2013). Inhibitory Effects of Resveratrol on PDGF-BB-Induced Retinal Pigment Epithelial Cell Migration via PDGFRβ, PI3K/Akt and MAPK pathways. PLoS ONE. 8(2). e56819–e56819. 63 indexed citations
9.
Chuang, Tzu‐Chao, et al.. (2011). Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells. Cancer Letters. 311(1). 11–19. 42 indexed citations
10.
Chen, Han‐Min, Ching‐Yu Lin, & Vinchi Wang. (2011). Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach. Clinical Biochemistry. 44(5-6). 377–385. 24 indexed citations
11.
Lin, Ching‐Yu, Vinchi Wang, Hao‐Ai Shui, et al.. (2009). A comprehensive evaluation of imidazole‐zinc reverse stain for current proteomic researches. PROTEOMICS. 9(3). 696–709. 20 indexed citations
13.
Wang, Vinchi, Tzu‐Chao Chuang, Bing‐Wen Soong, Din‐E Shan, & Ming‐Ching Kao. (2008). Octarepeat changes of prion protein in Parkinson's disease. Parkinsonism & Related Disorders. 15(1). 53–58. 16 indexed citations
14.
Wang, Vinchi, et al.. (2007). Polymorphism distribution of prion protein codon 117, 129 and 171 in Taiwan. European Journal of Epidemiology. 22(4). 257–261. 4 indexed citations
15.
Wang, Vinchi, Tzu‐Chao Chuang, Yaw‐Don Hsu, Wei‐Yuan Chou, & Ming‐Ching Kao. (2005). Nitric oxide induces prion protein via MEK and p38 MAPK signaling. Biochemical and Biophysical Research Communications. 333(1). 95–100. 20 indexed citations
16.
Wang, Vinchi, et al.. (2004). Effects of the Combined Treatment of Naloxone and Indomethacin on Catecholamines and Behavior After Intranigral Lipopolysaccharide Injection. Neurochemical Research. 29(2). 341–346. 12 indexed citations
17.
Chuang, Tzu‐Chao, Yi‐Jen Lee, Jah‐Yao Liu, et al.. (2003). EBNA1 may prolong G2/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs. Biochemical and Biophysical Research Communications. 307(3). 653–659. 10 indexed citations
18.
Chen, Chia‐Hsiang, et al.. (1998). Genetic polymorphism and Parkinson's disease in Taiwan: Study of debrisoquine 4-hydroxylase (CYP2D6). Journal of the Neurological Sciences. 158(1). 38–42. 4 indexed citations
19.
Yen, Der‐Jen, et al.. (1993). Reversible Motor Neuron Disease. European Neurology. 33(5). 387–389. 8 indexed citations
20.
Tsai, Ching‐Piao, et al.. (1993). Immunosuppressive Treatment in Lower Motor Neuron Syndrome with Autoantibodies against GM1 Ganglioside. European Neurology. 33(6). 446–449. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026